Cargando…
The economic and clinical burden of early versus late initiation of celecoxib among patients with osteoarthritis
OBJECTIVE: This study aimed to evaluate the characteristics associated with early versus late initiation of celecoxib treatment after osteoarthritis (OA) diagnosis and whether economic and safety outcomes differ between patients with early versus late initiation of celecoxib. METHODS: Adults (≥18 ye...
Autores principales: | Shelbaya, Ahmed, Solem, Caitlyn T, Walker, Chris, Wan, Yin, Johnson, Courtney, Cappelleri, Joseph C |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Dove Medical Press
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5896655/ https://www.ncbi.nlm.nih.gov/pubmed/29670383 http://dx.doi.org/10.2147/CEOR.S140208 |
Ejemplares similares
-
Economic Outcomes Related to Persistence and Dosing of Celecoxib in Patients with Osteoarthritis (OA) Using a Retrospective Claims Database Analysis
por: Johnson, Courtney, et al.
Publicado: (2020) -
Analysis of treatment patterns and persistence on branded and generic medications in major depressive disorder using retrospective claims data
por: Solem, Caitlyn T, et al.
Publicado: (2016) -
An economic model of long-term use of celecoxib in patients with osteoarthritis
por: Loyd, Michael, et al.
Publicado: (2007) -
A quality‐adjusted survival time without symptoms or toxicities analysis of glasdegib plus low‐dose cytarabine versus low‐dose cytarabine as initial therapy for acute myeloid leukemia in patients who are not considered candidates for intensive chemotherapy
por: Solem, Caitlyn T., et al.
Publicado: (2020) -
Efficacy of celecoxib versus ibuprofen for the treatment of patients with osteoarthritis of the knee: A randomized double-blind, non-inferiority trial
por: Gordo, Ana C, et al.
Publicado: (2017)